Search
for
Sort by
Research 30 of 133
- Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach
- Alopecia induced by dopamine agonists
- Mutation in 5′ upstream region of <i>GCH</i> I gene causes familial dopa-responsive dystonia
- Hair loss, old and uninterested nonmotor symptom in Parkinson’s disease during dopaminergic therapy
- Parkinson's disease and skin
- Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS database
- The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson’s disease
- Recommended Articles
- Pramipexole
- Role of Phenylalanine and Its Metabolites in Health and Neurological Disorders
- Drugs that affect autonomic functions or the extrapyramidal system
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- Dopamine is a novel, direct inducer of catagen in human scalp hair follicles<i>in vitro</i>
- Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis
- Imported cutaneous Leishmaniasis in Japan
- Telogen effluvium treated with Serenoa repens supplement
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- A rare case of azathioprine induced anagen effluvium and plica neuropathica
- Clinical case of a patient with progressive supranuclear palsy – from symptom to diagnosis
- Female hair loss
- Drug-induced changes in hair growth
- The Neurobiology of Sexual Function
- Telogen Effluvium
- Drug-Induced Hair Loss and Hair Growth
- Drug Reactions Affecting Hair: Diagnosis
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- DRUG‐ASSOCIATED ALOPECIA
- Anagen effluvium
- Absorption sites of orally administered drugs in the small intestine